The next in our NCRN virtual seminar series is this Wednesday (8th) at 12pm with @emilybhobson from @UEAPharmacy, who will be talking about "Targeting Nrf2 in non-small cell lung cancer". All are welcome to join via link: https://t.co/MY5HZmEErc #CancerInNorwich #NCRN https://t.co/XhNMadTkE5


from Twitter https://twitter.com/danbrewer

Comments

Post a Comment

Popular posts from this blog

A census of amplified and overexpressed human cancer genes : Nature Reviews Cancer

This paper , that I am an author on, was released on 24th December 2009: "Integrated genome-wide screens of DNA copy number and gene expression in human cancers have accelerated the rate of discovery of amplified and overexpressed genes. However, the biological importance of most of the genes identified in such studies remains unclear. In this Analysis, we propose a weight-of-evidence based classification system for identifying individual genes in amplified regions that are selected for during tumour development. In a census of the published literature we have identified 77 genes for which there is good evidence of involvement in the development of human cancer." I spent a huge amount of time on this one but I am still pretty low on the author pecking order. This is for a super high impact journal, "Nature Reviews Cancer" which has a 2008 ISI Impact Factor of 30.762. Also check out the associated website which I put together just before Christmas. Hopefully, this
Read more

GMail now with IMAP

GMail shakes IMAP out of coma | The Register Google has announced that gmail will now support IMAP. This means that gmail can be used in a normal email client such as Thunderbird rather than just on the web and the changes you make using that client will be reflected on the web version. I have been waiting for this one for a long time and I am very pleased with this news. I have managed to set it up without a problem, well apart from my work firewall blocking port 993 out for some version.
Read more